Dementia Clinical Trials
Here are the 6 most popular medical studies for dementia
Behavioral Intervention
Activity-based Companion Care for Dementia
This trial is testing whether a 12-week program delivered by older volunteers can help people with dementia and their caregivers. The volunteers will either serve in the program immediately (active duty) or after a 12-week waitlist period (control group).
Brain Stimulation
tDCS for Alzheimer's Dementia
This trial will study the mechanisms and treatment of neuropsychiatric symptoms in Alzheimer's dementia (AD) with the use of transcranial magnetic stimulation (TMS) combined with electroencephalography (EEG). The investigators will also evaluate if transcranial direct current stimulation (tDCS) is effective to treat agitation dementia.
Popular filter options for dementia trials
Mild Cognitive Impairment Clinical Trials
View 55 Mild Cognitive Impairment medical studies.
Tyrosine Kinase Inhibitor
TKIs for Dementia
This trial is designed to evaluate the tolerability and potential efficacy of tyrosine kinase inhibitors in patients with mild cognitive impairment or dementia. Baseline and outcome measures utilize validated tests that are appropriate for repeated measures. The study population is sufficiently broad and the conditions of interest are sufficiently prevalent so that recruitment of the projected numbers of subjects is not a limiting factor.
Phase 3 Dementia Clinical Trials
View 98 phase 3 dementia medical studies.
Monoclonal Antibodies
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
This trial is testing if an investigational product can improve Alzheimer's disease-related biomarkers and slow the rate of progression of cognitive or clinical impairment.
Dementia Clinical Trials With No Placebo
View 98 dementia medical studies that do not have a placebo group.
Tyrosine Kinase Inhibitor
TKIs for Dementia
This trial is designed to evaluate the tolerability and potential efficacy of tyrosine kinase inhibitors in patients with mild cognitive impairment or dementia. Baseline and outcome measures utilize validated tests that are appropriate for repeated measures. The study population is sufficiently broad and the conditions of interest are sufficiently prevalent so that recruitment of the projected numbers of subjects is not a limiting factor.
View More Dementia Trials
See another 75 medical studies focused on dementia.
Frequently Asked Questions
Introduction to dementia
What are the top hospitals conducting dementia research?
When it comes to advancing our understanding and treatment of dementia, several hospitals are leading the charge in clinical trials. In Cleveland, Case Western Reserve University has emerged as a prominent institution with three active trials focused on dementia. Since conducting their first recorded trial in 2019, they have contributed significantly to the field with six completed studies thus far. Similarly, the University of Minnesota in Minneapolis is making a significant impact through its ongoing collaborations on three active dementia trials and nine total trials since their initial research endeavor in 2018.
In Sun City at Banner Sun Health Research Institute, researchers have piloted groundbreaking investigations into dementia for over a decade. With three current clinical trials underway and an impressive sixteen completed studies under their belt since 2009, this institute continues to play a vital role in expanding our knowledge of this complex condition.
Meanwhile, Progressive Medical Research in Port Orange joins the ranks with its dedication to dementia research. Like their counterparts mentioned earlier, they currently conduct three active clinical trials and have made notable contributions through five previous studies since initiating their inaugural trial also back in 2019.
Finally, we look towards Missouri where the University of Missouri holds its own significance regarding dementia research. Though smaller-scale compared to some other institutions mentioned here; two ongoing clinical tests thrive alongside another fascinating aspect that marks them trailblazers around limited resources-three accomplished experiments conducted between timescales starting from early days tracing back until2003.
These hospitals represent beacons of hope for individuals affected by this debilitating condition and serve as pioneers shaping future treatments for better quality-of-life outcomes worldwide.
Which are the best cities for dementia clinical trials?
In the realm of dementia clinical trials, several cities stand out as hubs for research and exploration. Seattle, Washington leads with 13 active trials focused on a range of interventions like Survey-based Patient/Clinician Jumpstart and STAR-VTF. Toronto, Ontario follows closely behind with 9 ongoing studies investigating treatments including Escitalopram and VR&R Therapy. San Francisco, California also showcases its commitment to advancing dementia care through 9 active trials centered around Brain Health Intervention and Cognitive Training. Together, these cities offer individuals affected by dementia access to cutting-edge clinical trials that hold promise for improved understanding and management of this complex condition.
Which are the top treatments for dementia being explored in clinical trials?
Clinical trials for dementia are paving the way for new treatments and hope. Taking center stage is intervention, currently being explored in four active trials dedicated to dementia. Since its first listing in 2013, it has garnered a total of five trials focused on this debilitating condition. Close behind is cognitive training, with two ongoing trials and a history of four all-time dementia studies since its debut in 2019. These innovative approaches hold promise for improving the lives of those affected by dementia, offering glimpses of light amidst the challenges they face.
What are the most recent clinical trials for dementia?
Recent clinical trials bring hope to the field of dementia research, offering potential advancements in diagnosis, treatment, and care. One notable study explores the use of 123I-MIBG scintigraphy as a diagnostic tool for dementia. Another trial investigates the efficacy of Donanemab at dose level 4 in improving cognitive function and slowing disease progression. Additionally, an experimental treatment involving XPro1595 shows promise in addressing symptoms associated with dementia. Predicted Responders is another intriguing trial that aims to identify individuals who are likely to benefit from specific interventions. Finally, a Phase 3 study focuses on hearing intervention (HI) groups and their impact on mitigating cognitive decline related to dementia. These trials present diverse approaches towards understanding and combating this complex condition.
What dementia clinical trials were recently completed?
In the realm of dementia research, several noteworthy clinical trials have recently wrapped up, providing valuable insights into potential treatments. In April 2022, BioXcel Therapeutics Inc. completed a trial examining BXCL501's efficacy in addressing this debilitating condition. Prior to that, Eisai Inc.'s E2027 trial concluded in February 2021, followed by Axsome Therapeutics' AXS-05 study and Woolsey Pharmaceuticals' investigation on Oral Fasudil 90 mg/day both completing in December 2020. Moreover, Athira Pharma's ATH-1017 trial reached its endpoint in November 2020. These trials contribute to our understanding of various therapeutic avenues for dementia treatment and highlight ongoing efforts within the scientific community to combat this challenging disease effectively.